Pune study shows ‘promising results’ in bid to prevent TB among those at most risk

Post Date: 
Indian Express

While the outcome data of the study is yet to be officially released, The Indian Express has learnt that the interim results are “promising” and show that a short treatment regimen called “3HP”, which contains the drugs Isoniazid and Rifapentine administered once a week for three months could pave the way forward in successfully preventing TB. Currently, the preventive regimen among high-risk groups and household contacts of TB patients is Isoniazid to be taken daily for six months.